EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS): benefits for patients, families, and health care providers

Manon Engels iD, Katarzyna Urbanczyk, Jurriaan Hölzenspies iD, Claas Röhl iD, Nicoline Geverink, Nicoline Hoogerbrugge iD

Familial Cancer · 2025

DOI: 10.1007/s10689-025-00457-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Familial Cancer, 2025. Verfasst von Manon Engels und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands. manon.engels@radboudumc.nl. Hauptthemen laut MEDLINE: Neoplastic Syndromes, Hereditary, Genetic Predisposition to Disease. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union EU4H-2023-ERN2-IBA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS) established in 2017 and connecting more than 50 European expert centres improves access to diagnosis, treatment, and the provision of high-quality healthcare for patients with rare genetic tumour risk syndromes (hereditary cancer), no matter where they live in Europe.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Syndromes, HereditaryGenetic Predisposition to DiseaseHumansEuropeHealth PersonnelGenetic Testing

Stichwörter der Autor:innen

CareCross border health careEducationEuropean Reference NetworkGenetic tumour risk syndromeGuidelinesHereditary cancerPatientRare diseases

Autor:innen und Institutionen

  • Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands. manon.engels@radboudumc.nl.
  • Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands.
  • NF Kinder, Vienna, Austria.
  • Department of Experimental Urology, Radboud university medical center, Nijmegen, The Netherlands.

ORCID-Profile: Manon Engels, Jurriaan Hölzenspies, Claas Röhl, Nicoline Hoogerbrugge

Förderung

  • European Union EU4H-2023-ERN2-IBA

Zitieren

APA

Engels, M., Urbanczyk, K., Hölzenspies, J., Röhl, C., Geverink, N., & Hoogerbrugge, N. (2025). The European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS): benefits for patients, families, and health care providers. Familial Cancer. https://doi.org/10.1007/s10689-025-00457-9

Vancouver

Engels M, Urbanczyk K, Hölzenspies J, Röhl C, Geverink N, Hoogerbrugge N. The European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS): benefits for patients, families, and health care providers. Familial Cancer. 2025. doi:10.1007/s10689-025-00457-9

BibTeX
@article{Engels2025,
  author = {Engels, Manon and Urbanczyk, Katarzyna and Hölzenspies, Jurriaan and Röhl, Claas and Geverink, Nicoline and Hoogerbrugge, Nicoline},
  title = {The European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS): benefits for patients, families, and health care providers},
  journal = {Familial Cancer},
  year = {2025},
  doi = {10.1007/s10689-025-00457-9}
}
Kostenlos starten →